Views of prison staff in Scotland on the potential benefits and risks of e-cigarettes in smoke-free prisons: a qualitative focus group study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
25 06 2019
Historique:
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 9 6 2020
Statut: epublish

Résumé

Electronic cigarettes (e-cigarettes) were introduced into all Scottish prisons in February 2018, some months after prisons began preparing in 2017 for a smoking ban implemented in November 2018. In 2016/2017, prison staff views on the potential benefits and risks of e-cigarettes were explored in advance of the introduction of: (1) a smoking ban and (2) e-cigarettes. Fourteen prisons in Scotland. Seventeen focus groups and two paired interviews were conducted with 132 staff in 14 Scottish prisons 4-9 months before plans for a smoking ban were announced in July 2017. Both smoking and non-smoking staff were invited to participate. Prison staff highlighted three potential risks of e-cigarettes in smoke-free prisons: staff health risks from e-cigarette vapour; prisoner health risks from vaping; and risks to both groups from e-cigarette misuse, defects or accidents. Conversely, potential benefits of e-cigarettes in smoke-free prisons centred on: reducing smoking-related health harms to staff and prisoners; helping prisoners to manage without tobacco; and supporting staff to maintain safety and discipline in prison. Staff who participated in focus groups had limited experience of vaping and expressed some uncertainty and misunderstandings about e-cigarettes. Our findings highlight that scientific uncertainty, misunderstanding about vaping, the complexity of prisons as workplaces and prison tobacco control policy all have implications for staff perceptions of the potential place of e-cigarettes in smoke-free prisons. To alleviate staff concerns, there is a need for reliable information on e-cigarettes. Staff may also require reassurances on whether products are 'tamper proof', and rules about vaping indoors.

Identifiants

pubmed: 31243033
pii: bmjopen-2018-027799
doi: 10.1136/bmjopen-2018-027799
pmc: PMC6597633
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e027799

Subventions

Organisme : Chief Scientist Office
ID : SPHSU12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/12
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU-12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_13027
Pays : United Kingdom
Organisme : Department of Health
ID : PHR/15/55/44
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Tob Control. 2014 Nov;23(e2):e87-8
pubmed: 24713614
Addiction. 2018 Mar;113(3):391-404
pubmed: 28975720
Nicotine Tob Res. 2015 Jun;17(6):675-81
pubmed: 25358659
Eur J Public Health. 2017 Aug 1;27(4):729-736
pubmed: 28339940
Drug Alcohol Rev. 1998 Jun;17(2):213-9
pubmed: 16203486
JAMA Psychiatry. 2015 Feb;72(2):103-4
pubmed: 25471086
Nicotine Tob Res. 2019 Jul 17;21(8):1027-1035
pubmed: 29767777
Science. 2015 Jan 23;347(6220):375-6
pubmed: 25613878
Int J Environ Res Public Health. 2017 Aug 29;14(9):
pubmed: 28850065

Auteurs

Ashley Brown (A)

Institute for Social Marketing and Health, University of Stirling Institute for Social Marketing, Stirling, UK.

Helen Sweeting (H)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK.

Sean Semple (S)

Institute for Social Marketing and Health, University of Stirling Institute for Social Marketing, Stirling, UK.

Linda Bauld (L)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Evangelia Demou (E)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK.

Greig Logan (G)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Kate Hunt (K)

Institute for Social Marketing and Health, University of Stirling Institute for Social Marketing, Stirling, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH